13F-HR/A filed by Kalehua Capital Management LLC
Kalehua Capital Management LLC filed this 13F-HR/A for the quarter ended 2026-06-30, filed 2026-08-19, with 26 holding rows worth $173,960,282.
- Accession
- 0002106181-26-000008
- Filer
- CIK 2106181
- Filed
- 2026-08-19
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, amendment of type new holdings, 26 entries on the cover page, a total value of $173,960,282 stated on the cover page (in dollars after the unit check, H1), rows summing to $173,960,282 with VALUE read as dollars as filed, 13F file number 028-26381. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| EA SERIES TRUST | 02072L565 | ALPHA ARCH 1-3 | 226,188 | $26,484,353 | dollars as filed | |
| VERADERMICS INC | 922967104 | COMMON STOCK | 145,695 | $17,911,743 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 3,722,840 | $17,385,663 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 819,692 | $11,598,642 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 385,178 | $9,995,369 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 1,832,365 | $9,693,211 | dollars as filed | |
| SIONNA THERAPEUTICS INC | 829401108 | COMMON STOCK | 197,072 | $8,669,197 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 3,821,890 | $7,758,437 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 198,772 | $6,873,536 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U205 | COMMON STOCK | 685,644 | $6,698,742 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 194,544 | $6,515,279 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 2,897,769 | $6,491,003 | dollars as filed | |
| Cyclerion Therapeutics Inc | 23255M204 | COM | 1,651,350 | $5,598,077 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 405,040 | $5,338,427 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 79,407 | $3,657,486 | dollars as filed | |
| LeonaBio Inc | 04746L203 | COM | 393,701 | $3,618,112 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 139,000 | $3,615,390 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 175,734 | $3,421,541 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 226,415 | $2,603,773 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 74,465 | $2,378,412 | dollars as filed | |
| NUVECTIS PHARMA INC | 67080T108 | COMMON STOCK | 100,000 | $1,839,000 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 11,149,363 | $1,835,185 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 1,269,237 | $1,700,778 | dollars as filed | |
| ATYR PHARMA INC | 002120202 | COM NEW | 1,788,167 | $1,067,178 | dollars as filed | |
| Instil Bio Inc | 45783C200 | COM NEW | 99,600 | $765,924 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 454,876 | $445,824 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002106181-26-000007 | superseded | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0002106181-26-000008 | this filing | 2026-08-19 | acceptance time not in the bulk data set |